Cass considered that America's becoming dependent on a mercantilist dictatorship with a burgeoning industrial base was, at the very least, a national-security threat that couldn't be addressed by ...

SNIPR BIOME ApS (“SNIPR” or “the Company”), a clinical stage biotech company pioneering CRISPR-based therapies, today announces grant of patent EP4392563B on February 24th 2025 by the European Patent ...